Companies: 10,795·Total market cap: $144.5T
Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DCHPFOTCHealthcare
$46.90
$-0.10(-0.21%)
Market Cap$5.3B
P/E Ratio
52W High$47.4
52W Low$30.0

Dechra Pharmaceuticals PLC(DCHPF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · DCHPF · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-062022-062021-062020-062019-06
Revenue
Revenue$0.76B$0.68B$0.61B$0.52B$0.48B
Cost of Revenue$0.34B$0.30B$0.26B$0.22B$0.21B
Gross Profit$0.43B$0.38B$0.35B$0.29B$0.27B
Gross Margin %(computed)55.98%56.44%56.89%56.61%56.68%
Operating Expenses
R&D Expenses$0.06B$0.04B$0.03B$0.03B$0.03B
G&A Expenses$0.36B$0.18B$0.15B$0.13B$0.13B
Total Operating Expenses$0.42B$0.29B$0.26B$0.23B$0.23B
Operating Income$0.01B$0.10B$0.09B$0.06B$0.05B
Operating Margin %(computed)0.83%14.01%14.31%11.40%10.50%
Interest Income$0.00B$0.00B$0.01B$0.00B$0.01B
Interest Expense$0.04B$0.01B$0.01B$0.01B$0.01B
Income Before Tax($0.04B)$0.08B$0.07B$0.04B$0.03B
Income Tax Expense($0.01B)$0.02B$0.02B$0.01B($0.00B)
Net Income($0.03B)$0.06B$0.06B$0.03B$0.03B
Net Margin %(computed)-3.66%8.54%9.13%6.58%6.41%
Per Share & EBITDA
EPS (Basic)$-0.24$0.54$0.51$0.33$0.30
Wtd Avg Shares0.11B0.11B0.11B0.10B0.10B
EBITDA$0.09B$0.18B$0.12B$0.08B$0.07B
EBITDA Margin %(computed)11.39%26.24%20.23%15.76%14.86%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · GBP · B

深入了解Dechra Pharmaceuticals PLC

关于Dechra Pharmaceuticals PLC(DCHPF)损益表

Dechra Pharmaceuticals PLC(DCHPF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,DCHPF实现营收$0.76B,毛利润$0.43B(毛利率55.98%),净利润($0.03B)(净利率-3.66%)。

常见问题

DCHPF · 4 问

Dechra Pharmaceuticals PLC(DCHPF)2023财年营收为$0.76B,同比up11.7%。

DCHPF revenueDCHPF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08